World’s largest clinical trial of aspirin in cancer launches in UK
October 22, 2015Research and Development CRUK, Cancer, Cancer Research UK, aspirin, clinical trial, phase III
The world’s largest ever clinical trial has been launched across the UK today, to discover whether taking aspirin every day …
Revenues up at Biogen – but job losses planned
October 22, 2015Biogen, financial results, job losses, redundancies
Despite lower than predicted sales of its top-selling products, Biogen has achieved $2.8 billion in revenues in the third quarter …
Biogen’s natalizumab fails Phase III endpoints
October 21, 2015Biogen, multiple sclerosis
Biogen’s natalizumab has failed to achieve clinical endpoints in a late-stage study to prove the drug’s potential in patients with …
Encouraging late-stage results for Stelara in Crohn’s disease
October 21, 2015Research and Development, Sales and Marketing Crohn’s disease, Janssen, Stelera, crohn's disease, ustekinumab
Janssen is planning new regulatory submissions for Stelera after Phase III data found it improved responses and remission rates in …
DNA expands in London, appointing Heather Grant to lead new division
October 21, 2015Medical Communications
DNA’s well-established medical communications practice will now offer fully integrated healthcare communications to its clients. Neil Flash remains DNA’s managing …
DNA expands in London, appointing Heather Grant to lead new division
October 21, 2015Medical Communications
DNA’s well-established medical communications practice will now offer fully integrated healthcare communications to its clients. Neil Flash remains DNA’s managing …
Featured Market Report – Kidney Disease Global Clinical Trials Review
October 21, 2015Research and Development
GlobalData’s “Kidney Disease Global Clinical Trials Review, H2, 2015″ gives invaluable insight into the current state of clinical trials in …
Global warning for governments to step up R&D spending
October 21, 2015Research and Development
Countries should step up their investment in long-term R&D to develop disruptive technologies that will reshape industry, healthcare and communications, …
NICE issues draft guidance for MSD’s Ezetrol
October 21, 2015Sales and Marketing MSD, NICE, cardiovascular disease, ezetimibie, ezetrol, high cholesterol
NICE has published draft guidance recommending MSD’s Ezetrol as an option for some adults with high cholesterol. The guidance updates …
Future Focus: The industry’s top five biggest drug patent expirations in 2016
October 21, 2015Manufacturing and Production, Research and Development biosimilars, blockbuster, generics, patent cliff, patents
From Humira to Cubicin, some multi-billion dollar drugs are set to be hit hard by patent expiries next year, and …
Novartis acquires Admune Therapeutics
October 21, 2015Research and Development Admune Therapeutics, Cancer, Novartis, Palobiofarma, immunotherapy
Novartis is broadening its portfolio of cancer immunotherapies with the acquisition of Admune Therapeutics, and signing licensing agreements with Palobiofarma …
NHS research activity on the rise
October 21, 2015Research and Development
NHS England has achieved a significant increase in clinical research over the last year, according to new data from The …
Valeant announces strong Q3 results, will expand US contact lens plant
October 20, 2015Manufacturing and Production, Sales and Marketing Valeant, financial results, manufacturing, production
Valeant has announced plans to invest up to $150 million and add 200 jobs at its Bausch and Lomb plant …
‘Female Viagra’ goes on sale in the US
October 20, 2015Addyi, HSDD, Sprout, female viagra, flibanserin, hypoactive sexual desire disorder
The pill dubbed the female version of Viagra – Sprout Pharmaceuticals’ Addyi – has gone on sale in the US. …
Daiichi sheds more US jobs as generic losses take their toll
October 20, 2015Daiichi, Daiichi Sankyo, generic competition, generics, job losses, patent cliff, patents, redundancies
The Japan-based drugmaker Daiichi Sankyo is to cut up to 1,200 jobs – or about half its workforce – in …
Domainex and Imperial College London partner on heart attack treatments
October 20, 2015Research and Development Domainex cardiac arrest
Drug discovery company Domainex and Imperial College London have announced a new partnership aimed at discovering novel therapies to treat …
Synergy Vision expands global presence to meet demand in the Asia-Pacific region
October 20, 2015Medical Communications Asia-Pacific, Australia, Sydney, Synergy Vision, asia pacific, medical communcations
UK-based Synergy Vision opens a new office in Sydney, Australia, to meet the demands of their clients across the Asia-Pacific …
Recall after mislabelling of Medline Industries’ drugs
October 20, 2015Manufacturing and Production US, acetaminophen, paracetamol, product recall
Medline Industries is voluntarily carrying out a nationwide recall of the painkiller acetaminophen, due to a labelling error on the …
China’s Tianjin invests $300m in Ebola plant
October 20, 2015Manufacturing and Production China, Ebola, Ebola vaccine, manufacturing, production, vaccines
China’s Tianjin CanSino Biotechnology, a developer of affordable vaccines, says that it will invest 2 billion Yuan (£203.3 million) in …
UK ‘is the best place in the world to do big data’, says AAR lead
October 20, 2015Manufacturing and Production Accelerated Access Review, Big Data, Professor Sir John Bell
The UK is leading the world in developing new drugs from the analysis of big data, according to a leading …
Latest content
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
